A 29-year-old man with multiple sclerosis.
Rudick
R A
RA
Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Ohio State University, USA.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D001921:Brain / Q000473:pathology; D020022:Genetic Predisposition to Disease; D000068717:Glatiramer Acetate; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008329:Managed Care Programs; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D010455:Peptides / Q000627:therapeutic use; D011379:Prognosis; D011788:Quality of Life
D000276:Adjuvants, Immunologic; D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta